click below
click below
Normal Size Small Size show me how
PCSK9 Inhibitors
ch 20 hyperlipidemia, agents for cardiovascular system - pharm tech
| Question | Answer |
|---|---|
| PCSK9 | breaks down low-density lipoprotein (LDLP) which reduces LDL; currently two meds that inhibit this enzyme in the US |
| Repatha | evolocumab |
| Praluent | alirocumab |
| -mab | monoclonal antibodies |